BOSI, ALBERTO
BOSI, ALBERTO
Medicina Sperimentale e Clinica
. Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo).
1996 Buggia, I; Zecca, M; Alessandrino, Ep; Locatelli, F; Rosti, G; Bosi, A; Pession, A; Rotoli, B; Majolino, I; Dallorso, A; Regazzi, Mb.
18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.
2005 Rigacci, L; Castagnoli, A; Dini, C; Carpaneto, A; Matteini, M; Alterini, R; Carrai, V; Nassi, L; Bernardi, F; Pieroni, C; Bosi, Alberto
[The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases].
2005 Miniati I;Saccardi R;Pagliai F;Guiducci S;Bosi A;Guidi S;Urbani S;Tyndall A;Matucci Cerinic M
A case of disseminated Blastic Plasmocytoid Dendritic Cell Neoplasm
2018 Loscocco, Giuseppe G; Piccini, Matteo; Vergoni, Federica; Vannucchi, Alessandro M; Bosi, Alberto
A comparative analysis of biosimilar vs originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma; a propensity-score weighted multicenter approach
2017 Lanza, F; Saraceni, F; Pezzi, A; Martino, M; Bosi, A; Cascavilla, N; Musto, P; Zuffa, E; Tani, M; Cellini, C; Laszlo, D; Bonifazi, F
A life-threatening ruxolitinib discontinuation syndrome
2017 Coltro, Giacomo; Mannelli, Francesco; Guglielmelli, Paola; Pacilli, Annalisa; Bosi, Alberto; Vannucchi, Alessandro Maria
A policy for the disposal of autologous hematopoietic progenitor cells: Report from an Italian consensus panel
2014 Perseghin, Paolo; Marchetti, Monia; Pierelli, Luca; Olivieri, Attilio; Introna, Martino; Lombardini, Letizia; Accorsi, Patrizia; Petrini, Carlo; Risso, Marco; Bosi, Alberto
A prospective, open-label noncomparative study with piperacillin-tazobactam monotherapy as management of Fever in patients with acute leukemia.
2008 R. Fanci; B. Bartolozzi; G.Longo; A.Bosi
A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease
1999 MASSI D.; FRANCHI A.; PIMPINELLI N.; LASZLO D.; BOSI A.; M. SANTUCCI
A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease.
1999 Massi, D; Franchi, A; Pimpinelli, N; Laszlo, D; Bosi, Alberto; Santucci, M.
A sensitive detection method for MPLW515L or MPLW515K mutation in chronic myeloproliferative disorders with locked nucleic acid-modified probes and real-time polymerase chain reaction.
2008 Alessandro Pancrazzi; Paola Guglielmelli; Vanessa Ponziani; Gaetano Bergamaschi; Alberto Bosi; Giovanni Barosi; Alessandro M Vannucchi
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.
2008 Sierra, J; Szer, J; Kassis, J; Herrmann, R; Lazzarino, M; Thomas, X; Noga, Sj; Baker, N; Dansey, R; Bosi, Alberto
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis.
2014 Pieri L, Bonadonnap; Elena, C; Papayannidis, C; Grifoni, Fi; Rondoni, M; Girlanda, S; Mauro, M; Magliacane, D; Elli, Em; Iorno, Ml; Severino, M; Almerigogna, F; Scarfì, F; Bonifacio, M; Perbellini, O; Artuso, A; Soverini, S; De Benedittis, C; Muratori, S; Lunardon, L; Cova, V; Cortellini, G; Bosi, A; Cortelezzi, A; Martinelli, G; Triggiani, M; Merante, S; Vannucchi, Am
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
2012 Mannelli F;Bencini S;Peruzzi B;Cutini I;Sanna A;Benelli M;Magi A;Gianfaldoni G;Rotunno G;Carrai V;Gelli AM;Valle V;Santini V;Notaro R;Luzzatto L;Bosi A
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
2013 Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A.
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations.
2015 Pennucci, V1; Zini, R; Norfo, R; Guglielmelli, Paola; Bianchi, E; Salati, S; Sacchi, G; Prudente, Z; Tenedini, E; Ruberti, S; Paoli, C; Fanelli, Tiziana; Mannarelli, C; Tagliafico, E; Ferrari, S; Vannucchi, Am; Manfredini, R; Bogani, C; Bosi, Alberto; Fanelli, T; Fjerza, Rajmonda; Guglielmelli, P.
Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.
2005 A. M. Vannucchi;A. Pancrazzi;P. Guglielmelli;S. D. Lollo;C. Bogani;G. Baroni;L. Bianchi;A. R. Migliaccio;A. Bosi;F. Paoletti
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.
2011 Buchi F; Pastorelli R; Ferrari G; Spinelli E; Gozzini A; Sassolini F; Bosi A; Tombaccini D; Santini V
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.
2011 Buchi, F; Pastorelli, R; Ferrari, G; Spinelli, E; Gozzini, A; Sassolini, F; Bosi, Alberto; Tombaccini, D; Santini, Valeria
Acquired severe aplastic anemia after H1N1 influenza virus vaccination successfully treated with allogeneic bone marrow transplantation
2011 Donnini I; Scappini B; Guidi S; Longo G; Bosi A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| . Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo). | 1996 | Buggia, I; Zecca, M; Alessandrino, Ep; Locatelli, F; Rosti, G; Bosi, A; Pession, A; Rotoli, B; Majolino, I; Dallorso, A; Regazzi, Mb. | |
| 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results. | 2005 | Rigacci, L; Castagnoli, A; Dini, C; Carpaneto, A; Matteini, M; Alterini, R; Carrai, V; Nassi, L; Bernardi, F; Pieroni, C; Bosi, Alberto | |
| [The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases]. | 2005 | Miniati I;Saccardi R;Pagliai F;Guiducci S;Bosi A;Guidi S;Urbani S;Tyndall A;Matucci Cerinic M | |
| A case of disseminated Blastic Plasmocytoid Dendritic Cell Neoplasm | 2018 | Loscocco, Giuseppe G; Piccini, Matteo; Vergoni, Federica; Vannucchi, Alessandro M; Bosi, Alberto | |
| A comparative analysis of biosimilar vs originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma; a propensity-score weighted multicenter approach | 2017 | Lanza, F; Saraceni, F; Pezzi, A; Martino, M; Bosi, A; Cascavilla, N; Musto, P; Zuffa, E; Tani, M; Cellini, C; Laszlo, D; Bonifazi, F | |
| A life-threatening ruxolitinib discontinuation syndrome | 2017 | Coltro, Giacomo; Mannelli, Francesco; Guglielmelli, Paola; Pacilli, Annalisa; Bosi, Alberto; Vannucchi, Alessandro Maria | |
| A policy for the disposal of autologous hematopoietic progenitor cells: Report from an Italian consensus panel | 2014 | Perseghin, Paolo; Marchetti, Monia; Pierelli, Luca; Olivieri, Attilio; Introna, Martino; Lombardini, Letizia; Accorsi, Patrizia; Petrini, Carlo; Risso, Marco; Bosi, Alberto | |
| A prospective, open-label noncomparative study with piperacillin-tazobactam monotherapy as management of Fever in patients with acute leukemia. | 2008 | R. Fanci; B. Bartolozzi; G.Longo; A.Bosi | |
| A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease | 1999 | MASSI D.; FRANCHI A.; PIMPINELLI N.; LASZLO D.; BOSI A.; M. SANTUCCI | |
| A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease. | 1999 | Massi, D; Franchi, A; Pimpinelli, N; Laszlo, D; Bosi, Alberto; Santucci, M. | |
| A sensitive detection method for MPLW515L or MPLW515K mutation in chronic myeloproliferative disorders with locked nucleic acid-modified probes and real-time polymerase chain reaction. | 2008 | Alessandro Pancrazzi; Paola Guglielmelli; Vanessa Ponziani; Gaetano Bergamaschi; Alberto Bosi; Giovanni Barosi; Alessandro M Vannucchi | |
| A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial. | 2008 | Sierra, J; Szer, J; Kassis, J; Herrmann, R; Lazzarino, M; Thomas, X; Noga, Sj; Baker, N; Dansey, R; Bosi, Alberto | |
| A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis. | 2014 | Pieri L, Bonadonnap; Elena, C; Papayannidis, C; Grifoni, Fi; Rondoni, M; Girlanda, S; Mauro, M; Magliacane, D; Elli, Em; Iorno, Ml; Severino, M; Almerigogna, F; Scarfì, F; Bonifacio, M; Perbellini, O; Artuso, A; Soverini, S; De Benedittis, C; Muratori, S; Lunardon, L; Cova, V; Cortellini, G; Bosi, A; Cortelezzi, A; Martinelli, G; Triggiani, M; Merante, S; Vannucchi, Am | |
| A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. | 2012 | Mannelli F;Bencini S;Peruzzi B;Cutini I;Sanna A;Benelli M;Magi A;Gianfaldoni G;Rotunno G;Carrai V;Gelli AM;Valle V;Santini V;Notaro R;Luzzatto L;Bosi A | |
| A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. | 2013 | Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A. | |
| Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. | 2015 | Pennucci, V1; Zini, R; Norfo, R; Guglielmelli, Paola; Bianchi, E; Salati, S; Sacchi, G; Prudente, Z; Tenedini, E; Ruberti, S; Paoli, C; Fanelli, Tiziana; Mannarelli, C; Tagliafico, E; Ferrari, S; Vannucchi, Am; Manfredini, R; Bogani, C; Bosi, Alberto; Fanelli, T; Fjerza, Rajmonda; Guglielmelli, P. | |
| Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis. | 2005 | A. M. Vannucchi;A. Pancrazzi;P. Guglielmelli;S. D. Lollo;C. Bogani;G. Baroni;L. Bianchi;A. R. Migliaccio;A. Bosi;F. Paoletti | |
| Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. | 2011 | Buchi F; Pastorelli R; Ferrari G; Spinelli E; Gozzini A; Sassolini F; Bosi A; Tombaccini D; Santini V | |
| Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. | 2011 | Buchi, F; Pastorelli, R; Ferrari, G; Spinelli, E; Gozzini, A; Sassolini, F; Bosi, Alberto; Tombaccini, D; Santini, Valeria | |
| Acquired severe aplastic anemia after H1N1 influenza virus vaccination successfully treated with allogeneic bone marrow transplantation | 2011 | Donnini I; Scappini B; Guidi S; Longo G; Bosi A |